6589 Tai Kang Biotech Announces Scheduled Board Meeting for Q2 2026 Financial Report Review

Disclosure Date: 1150805 Statement Date: 1150804 Statement Time: 165818 Company Code: 6589 Company Name: Tai Kang Biotech Subject: The board of directors meeting to review the company's financial report for the second quarter of ROC Year 115 is scheduled for August 12, 2026. Compliance Clause: Clause 31 Event Date: 1150804 Details: 1. Board meeting notice date: 115/08/04 2. Scheduled board meeting date: 115/08/12 3. Financial report or self-compiled annual/quarterly financial information to be submitted to or approved by the board: Second Quarter 2026 Financial Report (ROC Year 115) 4. Other Matters to be Disclosed: None